等待开盘 03-26 09:30:00 美东时间
-0.080
-1.68%
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
Needham analyst Mike Cikos reiterates N-able (NYSE:NABL) with a Buy and maintains $8 price target.
03-19 20:06
N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced its selection as Manchester City's official cybersecurity partner, protecting critical systems, data, and daily
03-19 18:10
今日重点评级关注:HC Wainwright & Co.:维持Ardelyx"买入"评级,目标价从10美元升至18美元;Truist Securities:维持Praxis Precision Medicine"买入"评级,目标价从500美元升至700美元
02-23 08:56
Needham analyst Mike Cikos maintains N-able (NYSE:NABL) with a Buy and lowers the price target from $10 to $8.
02-20 18:55
N-able shares are trading lower after the company reported worse-than-expected ...
02-20 03:50
Financial Outlook for the First Quarter of 2026N-able management currently expects to achieve the following results for the first quarter of 2026:Total revenue in the range of $131 to $132 million, representing
02-19 20:07
Financial Outlook for the First Quarter of 2026N-able management currently expects to achieve the following results for the first quarter of 2026:Total revenue in the range of $131 to $132 million, representing
02-19 20:06
N-able (NYSE:NABL) announced its Q4 earnings on Thursday, February 19, 2026 at ...
02-19 20:02
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11